Durvalumab vs Tramadol

## Durvalumab vs Tramadol: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Tramadol**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Tramadol**: Mu-opioid receptor agonist and serotonin-norepinephrine reuptake inhibitor.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Tramadol — 5-7 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Tramadol — C16H25NO2.

**Molecular Weight**: Durvalumab — N/A; Tramadol — 263.3750 g/mol.

**Type**: Durvalumab — Antibody; Tramadol — Small molecule.